Chimeric antigen receptor T-cells: a review on current status and future directions for relapsed/refractory multiple myeloma.

Front Oncol · 2024 · PMC11338754 · PMID 39175472

Europe PMC DOI

hedged sentence

0.7200

closest p · 14.4× alpha

0.7200

boldest claim

The sentences

did not reach statistical significancep=0.72not close (p > 0.1)

Alternatively, the difference in PFS did not reach statistical significance among those with prior CAR-T cells (n=4, p=0.72).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.